Carcinoma: all 6,715 studies
Page 33 of 68. Open to participants first (1,140), then studies with results posted, then the rest; newest registration first within each.
- A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid TumorsWithdrawnNCT04791228Phase 2
- Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer TreatmentCompletedNCT04788264Not applicable
- A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)Status unknownNCT04787328Phase 2
- Volumetric Analysis of Hepatocellular Carcinoma After Transarterial ChemoembolizationCompletedNCT04780789
- Concurent Chemoradiotherapy in Head and Neck CancersStatus unknownNCT04780750Phase 3
- Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy in Patients With Peritoneal Carcinoma.CompletedNCT04779385
- Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric CancerStatus unknownNCT04778345Not applicable
- BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver CancerTerminatedNCT04777708Early Phase 1
- Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade LymphomasStatus unknownNCT04773769Not applicable
- Radioembolization for Hepatocellular Carcinoma With Portal Vein Tumoral ThrombosisCompletedNCT04771988
- Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic CharacteristicStatus unknownNCT04770974
- Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 InhibitorsCompletedNCT04767906Phase 2
- Role of LncRNA H19 in The Regulation of IGF-1R ExpressionCompletedNCT04767750
- A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC)Status unknownNCT04767295Phase 2
- Precisely Estimation of the Prognostic Value of Lymph Node in ESCCCompletedNCT04764240
- Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)Active, not recruitingNCT04764227Phase 2
- Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal CarcinomaStatus unknownNCT04764149
- Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver CirrhosisCompletedNCT04763707
- A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular CarcinomaCompletedNCT04763408
- SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein PositivityStatus unknownNCT04759261Not applicable
- Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCCStatus unknownNCT04759235
- 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
- A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell SurfaceCompletedNCT04752215Phase 1
- Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPCStatus unknownNCT04745741
- Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical TreatmentCompletedNCT04744688
- Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After SurgeryStatus unknownNCT04741490Not applicable
- Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT04741165Phase 2
- Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in ChinaStatus unknownNCT04740996
- Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid CancerWithdrawnNCT04739566Phase 2
- A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal CarcinomaCompletedNCT04736810Phase 2
- Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell CarcinomaCompletedNCT04735861Phase 2
- Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric StudyStatus unknownNCT04734691Phase 2
- Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid CancerWithdrawnNCT04731740Phase 2
- ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable orStatus unknownNCT04730388
- Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely ResectableStatus unknownNCT04730232Phase 2
- Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder CarcinomaStatus unknownNCT04730219Phase 2
- A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular CarcinomaCompletedNCT04728321Phase 2
- Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid CarcinomaStatus unknownNCT04725448Phase 2
- OPHTHALMOLOGIC EVALUATION OF RADIATION-RELATED OPTIC NEUROPATHY FOLLOWING IMAGE GUIDED INTENSITY-MODULATED RADIATION THERAPY (IMRT) FOR NASOPHARYNGEAL CARCİNOMAStatus unknownNCT04724590Not applicable
- Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal CarcinomaActive, not recruitingNCT04724239Phase 2
- Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular CarcinomaStatus unknownNCT04724226Phase 2
- Combined Therapy for Hepatocellular Carcinoma >3-<5 cmCompletedNCT04721470Not applicable
- JAB-3068 Activity in Adult Patients With Advanced Solid TumorsCompletedNCT04721223Phase 1/2
- Impact of Low Muscle Mass in HNC Treated With ImmunotherapyStatus unknownNCT04721184
- Blood Sample Collection for Experimental Blood Test to Track Liver CancerCompletedNCT04720430
- Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.Active, not recruitingNCT04719988Phase 2
- Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCCStatus unknownNCT04718909Phase 2
- Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04718415Phase 2
- A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric CarcinomaTerminatedNCT04718402Phase 1
- CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular CarcinomaStatus unknownNCT04715321
- Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)Status unknownNCT04713059
- Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib AloneCompletedNCT04710641Phase 2
- Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma with PVTTTerminatedNCT04709380Phase 3
- Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine CarcinomaCompletedNCT04705519Phase 2
- Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck StudyStatus unknownNCT04702347
- Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular CarcinomaCompletedNCT04701060Phase 2
- Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and DocetaxelStatus unknownNCT04699994Phase 2
- A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma DiagnosisStatus unknownNCT04699344
- Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell CarcinomaStatus unknownNCT04698213Phase 2
- External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCStatus unknownNCT04697446
- Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence AlgorithmStatus unknownNCT04695015
- Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageTerminatedNCT04688749
- Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 TrialStatus unknownNCT04687163Phase 3
- Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic CancersActive, not recruitingNCT04682847
- Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint InhibitorsWithdrawnNCT04680416
- Anti-PD1-antibody and Pulsed HHI for Advanced BCCActive, not recruitingNCT04679480Phase 2
- TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver TransplantationStatus unknownNCT04677088Phase 1
- Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard TherapyCompletedNCT04676633Phase 1
- Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.CompletedNCT04672772
- Neoadjuvant PD-1 Monoclonal Antibody in Cisplatin-ineligible High Risk Upper Tract Urothelial CarcinomaCompletedNCT04672330Phase 2
- Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial CarcinomaStatus unknownNCT04672317Phase 2
- Contrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell CarcinomaStatus unknownNCT04669613Not applicable
- HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority TrialStatus unknownNCT04667351Phase 3
- VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal CarcinomaStatus unknownNCT04666220
- A Study of SGN-STNV in Advanced Solid TumorsTerminatedNCT04665921Phase 1
- Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCCStatus unknownNCT04665609Phase 3
- IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCCStatus unknownNCT04665362Phase 1
- Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT04664582Not applicable
- Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous CarcinomaStatus unknownNCT04664244Phase 2
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsActive, not recruitingNCT04660929Phase 1
- Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCCTerminatedNCT04659369Phase 1
- Nurse-led Decision Counseling on Hepatocellular Carcinoma ScreeningCompletedNCT04659005Not applicable
- HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled TrialCompletedNCT04653818Phase 4
- Perioperative Therapy for Hepatocellular CarcinomaTerminatedNCT04653389Phase 2
- Tislelizumab in Combination With TACE in Advanced Hepatocellular CarcinomaStatus unknownNCT04652492Phase 2
- Ablation Combined With PD-1 in HCC: Phase II StudyStatus unknownNCT04652440Phase 1/2
- GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or PembrolizumabActive, not recruitingNCT04652076Phase 1/2
- SHR-1701 in Patients With Recurrent/Metastatic ScchnStatus unknownNCT04650633Phase 2
- The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin ResistanceTerminatedNCT04649671Not applicable
- Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.CompletedNCT04647981
- Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell CarcinomaStatus unknownNCT04644432Phase 2
- Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04644250Phase 2
- Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular CarcinomaCompletedNCT04642547Not applicable
- Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCCCompletedNCT04641637Not applicable
- Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCCStatus unknownNCT04639284
- De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04638465
- Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in EnglandCompletedNCT04637204
- Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal CarcinomaCompletedNCT04636632Phase 1
- A Phase Ⅱ Study of F520 in Patients With Urothelial CarcinomaStatus unknownNCT04636515Phase 2
- Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine CarcinomasStatus unknownNCT04635956Phase 2